Founded in 2015 by an international team of scientists in the fields of stem cells, regenerative medicine, and genetics, StemcellX has since expanded its Leadership Team to include experienced colleagues in corporate finance and regulatory affairs for veterinary medicinal product authorization.

Collaborating with veterinarians, StemcellX is developing a treatment for lameness in dogs resulting from osteoarthritis. Upon regulatory approval, the allogeneic stem cell therapy will restore an active, pain-free life for affected animals.